US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Health in Tech

0.7200

-0.1007-12.27%

Volume:436.26K

Turnover:309.95K

Market Cap:47.18M

PE:-11.03

High:0.7820

Open:0.7580

Low:0.6501

Close:0.8207

52wk High:4.02

52wk Low:0.6501

Shares:65.53M

Float Shares:20.30M

Volume Ratio:1.73

T/O Rate:2.15%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0653

EPS(LYR):0.0200

ROE:-21.91%

ROA:-12.72%

PB:2.41

PE(LYR):36.00

Loading ...

Overview Company News Filings

Cadrenal Therapeutics Launches Partnering Process as Its Cardiac Acute Critical Care Assets Advance to Transaction Readiness Following Landmark ISTH Data Presentation

Health in Tech Inc Expected to Post a Loss of 2 Cents a Share - Earnings Preview

Cadrenal Therapeutics’ Late-Breaking Phase 2 Data Demonstrate Greater Than 25% Reduction in Thrombotic Events in HIT for First-in-Class 12-LOX Inhibitor CAD-1005 at ISTH 2026 Congress

AJJ Medtech sets governance framework for HIT-1 humanoid eldercare platform

Cadrenal Therapeutics Announces up to $8.8 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Health In Tech Added to Russell Microcap Index

MT Newswires Live

Health In Tech added as member of Russell Microcap Index

Cadrenal Therapeutics Announces Selection of CAD-1005 Phase 2 Study for Late-Breaking Oral Presentation at ISTH 2026 Congress

Cadrenal Therapeutics to File for FDA Rare Pediatric Disease Designation for Tecarfarin in Kawasaki Disease

Cadrenal Therapeutics Advances Multi-Indication Strategy for CAD-1005; Launches Phase 2a Acute Kidney Injury (CSA-AKI) Clinical Plan to Accelerate Pharma Partnering at Upcoming BIO 2026

Health In Tech Files $300 Million Mixed Shelf Registration

MT Newswires Live

Health In Tech files $300M mixed securities shelf

Health in Tech - May Offer up to $300 Mln in Common Stock, Preferred Stock, Warrants, Debt, Rights, and Units - SEC Filing

THOMSON REUTERS

Cadrenal Therapeutics to Showcase Phase 3-Ready CAD-1005 and Novel 12-LOX Platform at BIO International Convention 2026 Partnering Event

Yantian International, Chengdu Land Port Company, and HIT Sign Cooperation Agreement

One-Year Milestone for Chengdu-Shenzhen-Hong Kong Scheduled Rail Service: Fostering Trilateral Synergy and Bolstering the Real Economy

Cadrenal Therapeutics to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026

Health In Tech Inc reports results for the quarter ended March 31 - Earnings Summary

Health In Tech reports Q1 EPS (3c), consensus (2c)

Health In Tech backs FY26 revenue view $45M-$50M, consensus $46.36M

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/HIT/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"HIT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HIT\",,,,,undefined,":{"symbol":"HIT","market":"US","secType":"STK","nameCN":"Health in Tech","latestPrice":0.72,"timestamp":1790865988852,"preClose":0.8207,"halted":0,"volume":436264,"delay":0,"changeRate":-0.12270013403192398,"floatShares":20299100,"shares":65529600,"eps":-0.0653,"marketStatus":"Trading","change":-0.1007,"latestTime":"10-01 10:47:05 EDT","open":0.758,"high":0.782,"low":0.6501,"amount":309945.31626248,"amplitude":0.160716,"askPrice":0.7199,"askSize":100,"bidPrice":0.6861,"bidSize":53,"shortable":0,"etf":0,"ttmEps":-0.0653,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1790884800000},"marketStatusCode":2,"adr":0,"listingDate":1734930000000,"exchange":"NASDAQ","adjPreClose":0.8207,"preHourTrading":{"tag":"盘前","latestPrice":0.758,"preClose":0.8207,"latestTime":"09:29 EDT","volume":39997,"amount":30178.0364775,"timestamp":1790861398402,"change":-0.0627,"changeRate":-0.076398,"amplitude":0.151822},"postHourTrading":{"tag":"盘后","latestPrice":0.79,"preClose":0.8207,"latestTime":"19:59 EDT","volume":6107440,"amount":5818515.885181,"timestamp":1790812780606,"change":-0.0307,"changeRate":-0.037407,"amplitude":0.402096},"volumeRatio":1.730518},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HIT\",,,,,undefined,":{"symbol":"HIT","floatShares":20299100,"roa":"-12.72%","roe":"-21.91%","lyrEps":0.02,"volumeRatio":1.730518,"shares":65529600,"dividePrice":0,"high":0.782,"amplitude":0.160716,"preClose":0.8207,"low":0.6501,"week52Low":0.6501,"pbRate":"2.41","psRate":"1.44","week52High":4.02,"institutionHeld":0,"latestPrice":0.72,"committee":-0.30719,"eps":-0.0653,"divideRate":0,"volume":436264,"delay":0,"ttmEps":-0.0653,"open":0.758,"prevYearClose":1.59,"prevWeekClose":0.86,"prevMonthClose":0.8207,"prevQuarterClose":0.8207,"fiveDayClose":0.8537,"twentyDayClose":0.9762,"sixtyDayClose":1.06},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HIT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"HIT","fiscalQuarterEnding":"2026/06","expectedEps":-0.03,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"post","actualEps":-0.04},{"market":"US","date":"2026-05-13","symbol":"HIT","fiscalQuarterEnding":"2026/03","expectedEps":-0.04,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778644800000,"reportTimeType":"post","actualEps":-0.03},{"market":"US","date":"2026-03-25","symbol":"HIT","fiscalQuarterEnding":"2025/12","expectedEps":-0.01,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774411200000,"reportTimeType":"post","actualEps":-0.01},{"market":"US","date":"2025-04-14","symbol":"HIT","fiscalQuarterEnding":"2025/03","expectedEps":0.02,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1744603200000,"reportTimeType":"post","actualEps":0.01}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HIT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HIT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1778817600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/HIT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"HIT","date":"2026-09-30","current":-12.568147,"percent":0.204082,"low":-99.750333,"twenty":-14.236586,"median":56.441063,"eighty":121.796762,"high":221.999544,"avg":55.622512,"sd":76.836403,"marketCap":55868295},"quantilePoints":[{"date":"2024-12-27","current":157.125683,"twenty":141.889253,"median":160.399135,"eighty":163.672587,"marketCap":285486210},{"date":"2025-01-03","current":155.340164,"twenty":156.054372,"median":159.431979,"eighty":163.196448,"marketCap":282242048},{"date":"2025-01-10","current":163.077413,"twenty":154.387887,"median":159.134392,"eighty":162.958378,"marketCap":296300081},{"date":"2025-01-17","current":169.029144,"twenty":154.625956,"median":159.506375,"eighty":163.672587,"marketCap":307113953},{"date":"2025-01-24","current":153.257058,"twenty":154.447404,"median":161.291894,"eighty":169.029144,"marketCap":278457193},{"date":"2025-01-31","current":183.90847,"twenty":154.447404,"median":161.887067,"eighty":169.624317,"marketCap":334148632},{"date":"2025-02-07","current":158.018442,"twenty":154.447404,"median":161.291894,"eighty":169.029144,"marketCap":287108290},{"date":"2025-02-14","current":176.766393,"twenty":155.340164,"median":162.779827,"eighty":171.409836,"marketCap":321171986},{"date":"2025-02-21","current":200.275728,"twenty":156.768579,"median":163.672587,"eighty":173.909563,"marketCap":363886779},{"date":"2025-02-28","current":207.417805,"twenty":157.83989,"median":165.458105,"eighty":181.765847,"marketCap":376863425},{"date":"2025-03-07","current":212.774362,"twenty":158.73265,"median":167.690004,"eighty":197.061793,"marketCap":386595909},{"date":"2025-03-14","current":32.734517,"twenty":157.83989,"median":169.029144,"eighty":199.323452,"marketCap":59476293},{"date":"2025-03-21","current":56.458248,"twenty":154.030783,"median":165.606898,"eighty":197.656967,"marketCap":37853957},{"date":"2025-03-28","current":55.854885,"twenty":145.69836,"median":163.672587,"eighty":197.061793,"marketCap":37449416},{"date":"2025-04-04","current":54.649326,"twenty":57.938837,"median":162.779827,"eighty":197.002276,"marketCap":36641116},{"date":"2025-04-11","current":52.572179,"twenty":55.748991,"median":161.291894,"eighty":191.050546,"marketCap":35248437},{"date":"2025-04-17","current":34.087191,"twenty":54.660513,"median":159.506375,"eighty":186.170128,"marketCap":36423288},{"date":"2025-04-25","current":33.769958,"twenty":52.396232,"median":159.134392,"eighty":182.301503,"marketCap":36084314},{"date":"2025-05-02","current":31.160461,"twenty":45.578303,"median":157.125683,"eighty":179.087568,"marketCap":33295981},{"date":"2025-05-09","current":39.930417,"twenty":35.548508,"median":154.298611,"eighty":177.659153,"marketCap":42666968},{"date":"2025-05-16","current":34.281623,"twenty":35.548508,"median":153.257058,"eighty":177.123497,"marketCap":36631046},{"date":"2025-05-23","current":33.258292,"twenty":34.731889,"median":135.699453,"eighty":174.62377,"marketCap":35537582},{"date":"2025-05-30","current":33.427142,"twenty":34.164964,"median":62.92533,"eighty":173.07632,"marketCap":35718004},{"date":"2025-06-06","current":32.245193,"twenty":33.613388,"median":57.019717,"eighty":172.302595,"marketCap":34455053},{"date":"2025-06-13","current":30.699962,"twenty":33.084325,"median":56.156566,"eighty":171.409836,"marketCap":32803922},{"date":"2025-06-20","current":30.699962,"twenty":32.521493,"median":55.626806,"eighty":171.290801,"marketCap":32803922},{"date":"2025-06-27","current":40.953749,"twenty":32.521493,"median":54.649326,"eighty":170.576594,"marketCap":43760432},{"date":"2025-07-03","current":43.537662,"twenty":32.644293,"median":53.403037,"eighty":169.624317,"marketCap":46521429},{"date":"2025-07-11","current":56.794929,"twenty":32.734517,"median":52.352245,"eighty":169.029144,"marketCap":60687256},{"date":"2025-07-18","current":61.399923,"twenty":33.002459,"median":53.724933,"eighty":166.350865,"marketCap":65607844},{"date":"2025-07-25","current":80.355571,"twenty":33.207125,"median":54.437195,"eighty":165.755692,"marketCap":109376548},{"date":"2025-08-01","current":85.740222,"twenty":33.258292,"median":55.423164,"eighty":165.458105,"marketCap":116705904},{"date":"2025-08-08","current":95.681118,"twenty":33.427142,"median":55.842666,"eighty":164.267759,"marketCap":130237023},{"date":"2025-08-15","current":134.225003,"twenty":33.509008,"median":56.458248,"eighty":163.672587,"marketCap":182701302},{"date":"2025-08-22","current":141.681948,"twenty":33.769958,"median":56.907323,"eighty":163.672587,"marketCap":192851375},{"date":"2025-08-29","current":115.996916,"twenty":33.826241,"median":58.296911,"eighty":163.077413,"marketCap":157890014},{"date":"2025-09-05","current":116.411191,"twenty":33.871267,"median":61.399923,"eighty":162.601275,"marketCap":158453907},{"date":"2025-09-12","current":115.582641,"twenty":33.960297,"median":65.505359,"eighty":162.006102,"marketCap":157326121},{"date":"2025-09-19","current":146.238969,"twenty":34.065701,"median":68.343655,"eighty":161.410929,"marketCap":199054197},{"date":"2025-09-26","current":136.296377,"twenty":34.242737,"median":75.592225,"eighty":161.291894,"marketCap":185520767},{"date":"2025-10-03","current":145.41042,"twenty":34.400329,"median":82.840795,"eighty":159.863479,"marketCap":197926411},{"date":"2025-10-10","current":142.510497,"twenty":34.597833,"median":90.503568,"eighty":159.506375,"marketCap":193979161},{"date":"2025-10-17","current":142.096223,"twenty":34.762589,"median":102.722585,"eighty":159.387341,"marketCap":193415268},{"date":"2025-10-24","current":124.28241,"twenty":34.80557,"median":108.747109,"eighty":159.000478,"marketCap":169167873},{"date":"2025-10-31","current":108.125697,"twenty":35.001026,"median":110.197071,"eighty":158.196994,"marketCap":147176049},{"date":"2025-11-07","current":115.996916,"twenty":35.126896,"median":111.232757,"eighty":157.304235,"marketCap":157890014},{"date":"2025-11-14","current":65.041128,"twenty":35.682565,"median":110.611345,"eighty":156.370386,"marketCap":88531186},{"date":"2025-11-21","current":49.494631,"twenty":36.438807,"median":109.575659,"eighty":155.508444,"marketCap":71136010},{"date":"2025-11-28","current":60.185471,"twenty":37.969712,"median":108.125697,"eighty":154.804508,"marketCap":86501388},{"date":"2025-12-05","current":50.286545,"twenty":39.123499,"median":102.722585,"eighty":154.268852,"marketCap":72274186},{"date":"2025-12-12","current":41.971447,"twenty":39.670818,"median":90.503568,"eighty":153.792714,"marketCap":60323336},{"date":"2025-12-19","current":53.850158,"twenty":40.532136,"median":85.740222,"eighty":153.376093,"marketCap":77395978},{"date":"2025-12-26","current":60.185471,"twenty":40.941469,"median":80.355571,"eighty":152.899954,"marketCap":86501388},{"date":"2026-01-02","current":62.95717,"twenty":41.131809,"median":75.81227,"eighty":152.364298,"marketCap":90485004},{"date":"2026-01-09","current":63.353127,"twenty":41.869528,"median":71.272268,"eighty":151.636362,"marketCap":91054092},{"date":"2026-01-16","current":55.433987,"twenty":41.971447,"median":68.343655,"eighty":148.393197,"marketCap":79672331},{"date":"2026-01-23","current":58.601643,"twenty":41.971447,"median":67.881746,"eighty":147.067519,"marketCap":84225035},{"date":"2026-01-30","current":47.118888,"twenty":41.971447,"median":66.520784,"eighty":146.238969,"marketCap":67721481},{"date":"2026-02-06","current":39.591745,"twenty":41.971447,"median":65.041128,"eighty":145.824695,"marketCap":56903117},{"date":"2026-02-13","current":42.763361,"twenty":41.971447,"median":63.551106,"eighty":145.824695,"marketCap":61461512},{"date":"2026-02-20","current":42.458474,"twenty":41.971447,"median":63.24105,"eighty":145.493275,"marketCap":61023314},{"date":"2026-02-27","current":53.454201,"twenty":42.254301,"median":62.721688,"eighty":145.079,"marketCap":76826890},{"date":"2026-03-06","current":66.520784,"twenty":42.431782,"median":62.443472,"eighty":144.664725,"marketCap":95606797},{"date":"2026-03-13","current":76.815667,"twenty":42.702384,"median":63.128972,"eighty":143.919031,"marketCap":110403087},{"date":"2026-03-20","current":79.19141,"twenty":42.763361,"median":63.551106,"eighty":143.090481,"marketCap":113817616},{"date":"2026-03-27","current":72.649053,"twenty":42.763361,"median":64.540999,"eighty":142.593352,"marketCap":92906660},{"date":"2026-04-02","current":72.794568,"twenty":42.763361,"median":65.041128,"eighty":142.510497,"marketCap":93092751},{"date":"2026-04-10","current":71.769293,"twenty":42.834982,"median":66.322806,"eighty":142.261933,"marketCap":91781586},{"date":"2026-04-17","current":73.819844,"twenty":42.993249,"median":67.312698,"eighty":141.847658,"marketCap":94403917},{"date":"2026-04-24","current":77.408308,"twenty":43.122362,"median":67.688423,"eighty":141.681948,"marketCap":98992996},{"date":"2026-05-01","current":74.332482,"twenty":43.386324,"median":67.929451,"eighty":140.936253,"marketCap":95059500},{"date":"2026-05-08","current":80.448884,"twenty":43.537662,"median":68.725663,"eighty":139.941994,"marketCap":102881412},{"date":"2026-05-15","current":-99.750333,"twenty":43.537662,"median":68.80861,"eighty":139.113444,"marketCap":80601361},{"date":"2026-05-22","current":-74.812749,"twenty":42.834982,"median":68.518561,"eighty":138.284895,"marketCap":60451020},{"date":"2026-05-29","current":-79.273129,"twenty":42.763361,"median":67.905598,"eighty":137.622056,"marketCap":64055146},{"date":"2026-06-05","current":-81.097832,"twenty":41.971447,"median":67.66819,"eighty":136.959216,"marketCap":65529562},{"date":"2026-06-12","current":-85.963701,"twenty":41.682913,"median":67.11472,"eighty":136.544941,"marketCap":69461335},{"date":"2026-06-18","current":-85.963701,"twenty":40.13099,"median":66.322806,"eighty":136.213522,"marketCap":69461335},{"date":"2026-06-26","current":-78.656787,"twenty":37.052807,"median":65.041128,"eighty":135.799247,"marketCap":63557122},{"date":"2026-07-02","current":-85.963701,"twenty":35.049122,"median":64.353376,"eighty":135.467827,"marketCap":69461335},{"date":"2026-07-10","current":-88.396636,"twenty":34.430006,"median":63.551106,"eighty":134.225003,"marketCap":71427222},{"date":"2026-07-17","current":-86.774679,"twenty":33.882524,"median":63.128972,"eighty":134.225003,"marketCap":70116631},{"date":"2026-07-24","current":-85.98016,"twenty":33.427142,"median":62.443472,"eighty":132.982179,"marketCap":69474635},{"date":"2026-07-31","current":-84.357893,"twenty":32.948871,"median":61.429682,"eighty":132.982179,"marketCap":68163793},{"date":"2026-08-07","current":-90.846963,"twenty":32.464186,"median":60.185471,"eighty":132.982179,"marketCap":73407162},{"date":"2026-08-14","current":-85.98016,"twenty":32.12751,"median":60.185471,"eighty":131.6565,"marketCap":69474635},{"date":"2026-08-21","current":-16.924219,"twenty":31.714084,"median":58.601643,"eighty":127.348043,"marketCap":66845351},{"date":"2026-08-28","current":-16.59569,"twenty":31.190138,"median":58.057586,"eighty":125.359524,"marketCap":65547764},{"date":"2026-09-04","current":-16.582416,"twenty":30.699962,"median":57.413772,"eighty":124.44812,"marketCap":65495337},{"date":"2026-09-11","current":-15.444179,"twenty":30.434918,"median":57.413772,"eighty":124.28241,"marketCap":60999659},{"date":"2026-09-18","current":-13.439821,"twenty":24.521129,"median":56.906372,"eighty":123.536716,"marketCap":53083072},{"date":"2026-09-25","current":-14.164908,"twenty":-14.128073,"median":56.506539,"eighty":122.293892,"marketCap":55946937},{"date":"2026-09-30","current":-14.144997,"twenty":-14.236586,"median":56.441063,"eighty":121.796762,"marketCap":55868295}],"updateTime":1790858442922},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HIT\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2653277765","title":"Cadrenal Therapeutics Launches Partnering Process as Its Cardiac Acute Critical Care Assets Advance to Transaction Readiness Following Landmark ISTH Data Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2653277765","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653277765?lang=en_us&edition=fundamental","pubTime":"2026-07-21 20:00","pubTimestamp":1784635200,"startTime":"0","endTime":"0","summary":"Capital-efficient strategy focuses on differentiated therapies for cardiac pre- and post-operative critical care and orphan cardiovascular conditionsCompany is exploring development, licensing, and co","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/21/3330413/0/en/Cadrenal-Therapeutics-Launches-Partnering-Process-as-Its-Cardiac-Acute-Critical-Care-Assets-Advance-to-Transaction-Readiness-Following-Landmark-ISTH-Data-Presentation.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ODD","IE00B7SZL793.SGD","BK4173","IE00B19Z4B17.USD","BK4134","BK4539","BK4139","IE0009354923.USD","BK4211","KD","IE00B66KJ199.SGD","LENZ","BK4183","LARK","BK4007","HIT","IE0031619046.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652013280","title":"Health in Tech Inc Expected to Post a Loss of 2 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2652013280","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652013280?lang=en_us&edition=fundamental","pubTime":"2026-07-18 04:27","pubTimestamp":1784320028,"startTime":"0","endTime":"0","summary":"Health In Tech Incexpected to post a loss of2cents a share - Earnings PreviewHealth In Tech IncHIT.OQHIT.Ois expected to  show a fall in quarterly revenue when it reports  results on July 20 (estimate","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260717:nL8N43J1Y1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIT","BK4173"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651146031","title":"Cadrenal Therapeutics’ Late-Breaking Phase 2 Data Demonstrate Greater Than 25% Reduction in Thrombotic Events in HIT for First-in-Class 12-LOX Inhibitor CAD-1005 at ISTH 2026 Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2651146031","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651146031?lang=en_us&edition=fundamental","pubTime":"2026-07-13 21:00","pubTimestamp":1783947600,"startTime":"0","endTime":"0","summary":"Selected as one of three late-breakthrough abstracts: clinical trials and innovation in thrombosis, CAD-1005 took center stage before the global thrombosis community at the largest ISTH meeting in mor","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/13/3326228/0/en/Cadrenal-Therapeutics-Late-Breaking-Phase-2-Data-Demonstrate-Greater-Than-25-Reduction-in-Thrombotic-Events-in-HIT-for-First-in-Class-12-LOX-Inhibitor-CAD-1005-at-ISTH-2026-Congres.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4081","HIT","IE00B7SZL793.SGD","IE00B66KJ199.SGD","IE0031619046.USD","IE00B19Z4B17.USD","LENZ","BK4007","KD","BK4173","BK4139","BK4539","EMA","BK4134"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651612731","title":"AJJ Medtech sets governance framework for HIT-1 humanoid eldercare platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2651612731","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651612731?lang=en_us&edition=fundamental","pubTime":"2026-07-13 08:02","pubTimestamp":1783900943,"startTime":"0","endTime":"0","summary":"AJJ Medtech Holdings Limited ( ($SG:584) ) just unveiled an update. AJJ Medtech Holdings has released a detailed public-facing Q&A to explain the A...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ajj-medtech-sets-governance-framework-for-hit-1-humanoid-eldercare-platform?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ajj-medtech-sets-governance-framework-for-hit-1-humanoid-eldercare-platform?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SG","BK4209","HIT","BK4173"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648593971","title":"Cadrenal Therapeutics Announces up to $8.8 Million Private Placement Priced At-The-Market Under Nasdaq Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2648593971","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648593971?lang=en_us&edition=fundamental","pubTime":"2026-07-01 08:00","pubTimestamp":1782864000,"startTime":"0","endTime":"0","summary":"$3 million upfront with up to approximately $5.8 million of potential additional gross proceeds upon the exercise in full of warrants Net proceeds anticipated to extend cash runway into first quarter ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/01/3320268/0/en/Cadrenal-Therapeutics-Announces-up-to-8-8-Million-Private-Placement-Priced-At-The-Market-Under-Nasdaq-Rules.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","IE00B7SZL793.SGD","BK4139","BK4007","BK4173","HIT","BK4134","IE0031619046.USD","KD","IE00B19Z4B17.USD","BK4539","IE00B66KJ199.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647737408","title":"Health In Tech Added to Russell Microcap Index","url":"https://stock-news.laohu8.com/highlight/detail?id=2647737408","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647737408?lang=en_us&edition=fundamental","pubTime":"2026-06-29 21:08","pubTimestamp":1782738539,"startTime":"0","endTime":"0","summary":"Health In Tech  said Monday it has been added as a member of the Russell Microcap Index, effective at the start of the trading session today.The addition comes as part of the annual Russell US indexes reconstitution, according to a statement.Shares of the company were down 4.9% in Monday premarket trading.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7057","HIT.AU","HIT","BK4173"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647373805","title":"Health In Tech added as member of Russell Microcap Index","url":"https://stock-news.laohu8.com/highlight/detail?id=2647373805","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647373805?lang=en_us&edition=fundamental","pubTime":"2026-06-29 18:10","pubTimestamp":1782727835,"startTime":"0","endTime":"0","summary":"Health In Tech (HIT) was added as a member of the Russell Microcap Index, effective when the U.S. market opens on June 29, as part of the 2026 Russ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/health-in-tech-added-as-member-of-russell-microcap-index-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/health-in-tech-added-as-member-of-russell-microcap-index-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HIT","BK4173"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645818942","title":"Cadrenal Therapeutics Announces Selection of CAD-1005 Phase 2 Study for Late-Breaking Oral Presentation at ISTH 2026 Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2645818942","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645818942?lang=en_us&edition=fundamental","pubTime":"2026-06-24 20:00","pubTimestamp":1782302400,"startTime":"0","endTime":"0","summary":"Selection highlights the clinical value potential of Cadrenal’s first-in-class 12-lipoxygenase inhibitor for Heparin-Induced Thrombocytopenia (HIT) First-ever randomized, blinded, placebo-controlled t","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/24/3316790/0/en/Cadrenal-Therapeutics-Announces-Selection-of-CAD-1005-Phase-2-Study-for-Late-Breaking-Oral-Presentation-at-ISTH-2026-Congress.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIT","IE00B7SZL793.SGD","IE00B66KJ199.SGD","IE0031619046.USD","IE00B19Z4B17.USD","LENZ","BK4007","KD","BK4173","BK4139","BK4539","BK4134"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644896240","title":"Cadrenal Therapeutics to File for FDA Rare Pediatric Disease Designation for Tecarfarin in Kawasaki Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2644896240","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644896240?lang=en_us&edition=fundamental","pubTime":"2026-06-18 21:00","pubTimestamp":1781787600,"startTime":"0","endTime":"0","summary":"Company to present Phase 3-ready pipeline, 12-LOX platform, and pediatric rare-disease expansion to global pharmaceutical partners at the 2026 BIO International Convention in San Diego Kawasaki diseas","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/18/3314211/0/en/Cadrenal-Therapeutics-to-File-for-FDA-Rare-Pediatric-Disease-Designation-for-Tecarfarin-in-Kawasaki-Disease.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIT","LENZ","IE00B7SZL793.SGD","BK4139","IE00B19Z4B17.USD","BK4539","IE0031619046.USD","BK4134","BK4588","IE00B66KJ199.SGD","KD","BK4007","BK4173","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643205436","title":"Cadrenal Therapeutics Advances Multi-Indication Strategy for CAD-1005; Launches Phase 2a Acute Kidney Injury (CSA-AKI) Clinical Plan to Accelerate Pharma Partnering at Upcoming BIO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2643205436","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643205436?lang=en_us&edition=fundamental","pubTime":"2026-06-15 20:30","pubTimestamp":1781526600,"startTime":"0","endTime":"0","summary":"New high-value indication for Phase 3-ready asset with data intended to support clinical development and strategic partnering discussionsAdditional billion-dollar target- Cardiac Surgery-Associated Ac","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/15/3311786/0/en/Cadrenal-Therapeutics-Advances-Multi-Indication-Strategy-for-CAD-1005-Launches-Phase-2a-Acute-Kidney-Injury-CSA-AKI-Clinical-Plan-to-Accelerate-Pharma-Partnering-at-Upcoming-BIO-20.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CPB","BK4007","BK4588","BK4183","ODD","IE0009354923.USD","BK4585","BK4539","BK4139","BK4212","BIO","BK4173","LENZ","LU1169590202.USD","BK4121","AAQC","LU0149725797.USD","HIT","CSA","IE00BHPRN162.USD","LU1169589451.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642235447","title":"Health In Tech Files $300 Million Mixed Shelf Registration","url":"https://stock-news.laohu8.com/highlight/detail?id=2642235447","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642235447?lang=en_us&edition=fundamental","pubTime":"2026-06-12 00:45","pubTimestamp":1781196337,"startTime":"0","endTime":"0","summary":"Health In Tech  Thursday filed a registration statement with the US Securities and Exchange Commission for the potential sale of up to $300 million in securities.The filing covers common stock, preferred stock, warrants, debt securities, subscription rights and units, according to the filing.Proceeds from the offering will be used for general corporate purposes, the company said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7057","HIT.AU","HIT","BK4173"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642235106","title":"Health In Tech files $300M mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2642235106","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642235106?lang=en_us&edition=fundamental","pubTime":"2026-06-12 00:25","pubTimestamp":1781195109,"startTime":"0","endTime":"0","summary":"12:24 EDT Health In Tech (HIT) files $300M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving brea...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/health-in-tech-files-300m-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/health-in-tech-files-300m-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4173","HIT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642235616","title":"Health in Tech - May Offer up to $300 Mln in Common Stock, Preferred Stock, Warrants, Debt, Rights, and Units - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2642235616","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642235616?lang=en_us&edition=fundamental","pubTime":"2026-06-12 00:22","pubTimestamp":1781194959,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260611:nFWN42J107:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4173","HIT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640076399","title":"Cadrenal Therapeutics to Showcase Phase 3-Ready CAD-1005 and Novel 12-LOX Platform at BIO International Convention 2026 Partnering Event","url":"https://stock-news.laohu8.com/highlight/detail?id=2640076399","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640076399?lang=en_us&edition=fundamental","pubTime":"2026-06-03 21:00","pubTimestamp":1780491600,"startTime":"0","endTime":"0","summary":"Lead asset CAD-1005 being researched for prevention of life-threatening blood clots in patients with Heparin-induced Thrombocytopenia (HIT), targets $2 billion peak annual revenue potential 12-LOX cou","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/03/3306100/0/en/Cadrenal-Therapeutics-to-Showcase-Phase-3-Ready-CAD-1005-and-Novel-12-LOX-Platform-at-BIO-International-Convention-2026-Partnering-Event.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1169589451.USD","BIO","BK4173","BK4121","LENZ","LU1169590202.USD","BK4585","BK4139","BK4007","BK4539","HIT","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164684664","title":"Yantian International, Chengdu Land Port Company, and HIT Sign Cooperation Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=1164684664","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164684664?lang=en_us&edition=fundamental","pubTime":"2026-05-29 18:41","pubTimestamp":1780051275,"startTime":"0","endTime":"0","summary":"The stable operation of the \"Chengdu-Shenzhen-Hong Kong Fixed-Schedule Train\" represents a concrete practice in deepening logistics coordination and promoting regional interconnected development...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIT","BK4173"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178019222","title":"One-Year Milestone for Chengdu-Shenzhen-Hong Kong Scheduled Rail Service: Fostering Trilateral Synergy and Bolstering the Real Economy","url":"https://stock-news.laohu8.com/highlight/detail?id=1178019222","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178019222?lang=en_us&edition=fundamental","pubTime":"2026-05-29 07:51","pubTimestamp":1780012301,"startTime":"0","endTime":"0","summary":"A ceremony and client promotion event marking the first anniversary of the inaugural \"Chengdu-Shenzhen-Hong Kong Scheduled Rail Service\" was successfully held in Chengdu. (May 28, Chengdu, China)...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4173","HIT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636864055","title":"Cadrenal Therapeutics to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2636864055","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636864055?lang=en_us&edition=fundamental","pubTime":"2026-05-20 04:30","pubTimestamp":1779222600,"startTime":"0","endTime":"0","summary":"PONTE VEDRA, Fla., May  19, 2026  (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a late-stage biopharmaceutical company advancing novel therapies for life-threatening immune and throm","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/19/3297984/0/en/Cadrenal-Therapeutics-to-Participate-in-the-Lytham-Partners-Spring-2026-Investor-Conference-on-May-28-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","HIT","BK4539","BK4173","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635759055","title":"Health In Tech Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2635759055","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635759055?lang=en_us&edition=fundamental","pubTime":"2026-05-14 05:47","pubTimestamp":1778708876,"startTime":"0","endTime":"0","summary":"Health In Tech Inc reports results for the quarter ended March 31 - Earnings SummaryHealth In Tech Inc HIT.OQ reported a quarterly adjusted loss of 3 cents per share for the quarter ended March 31, lo","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nL8N41Q2Y8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIT","BK4173"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635753471","title":"Health In Tech reports Q1 EPS (3c), consensus (2c)","url":"https://stock-news.laohu8.com/highlight/detail?id=2635753471","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635753471?lang=en_us&edition=fundamental","pubTime":"2026-05-14 04:09","pubTimestamp":1778702968,"startTime":"0","endTime":"0","summary":"Reports Q1 revenue $8.8M, consensus $7.46M. Tim Johnson, Chief Executive Officer of Health In Tech (HIT), commented, “In the first quarter of 2026,...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/health-in-tech-reports-q1-eps-3c-consensus-2c-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/health-in-tech-reports-q1-eps-3c-consensus-2c-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HIT","BK4173"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635753260","title":"Health In Tech backs FY26 revenue view $45M-$50M, consensus $46.36M","url":"https://stock-news.laohu8.com/highlight/detail?id=2635753260","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635753260?lang=en_us&edition=fundamental","pubTime":"2026-05-14 04:06","pubTimestamp":1778702816,"startTime":"0","endTime":"0","summary":"Health In Tech (HIT) reiterated guidance for 2026 annual revenue ranging between $45M-$50M, representing year-over-year growth of approximately 35%...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/health-in-tech-backs-fy26-revenue-view-45m-50m-consensus-46-36m-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/health-in-tech-backs-fy26-revenue-view-45m-50m-consensus-46-36m-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4173","HIT"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":53,"code":"91000000","status":"200"}]}}